Varitect® CP
Immunoglobuline humaine spécifique anti-VZV pour application intraveineuse

Références (sont remis sur demande):

  1. www.pptaglobal.org/program/qseal.aspx
  2. Information professionnelle, mars 2012, swissmedicinfo.com
  3. OFSP Bulletin 47 du 20 novembre 2017, p. 12 – 15
  4. Paul R., Singhania P., Hashmi M., et al. : Post chicken pox neurological sequelae : three distinct presentations. J Neurosci Rural Pract (2010) 1: p. 92-96.
  5. Kempf W. et al. : Swiss recommendations for the management of varicella zoster virus infections. Swiss Med wkly (2007) 137: p. 239-251
  6. Gnann JW Jr. : Varicella-zoster virus : atypical presentations and unusual complications. J Infect Dis (2002) 186: p. 91-98
  7. Keating GM, : Shingles (herpes zoster) vaccine (zostavax (®)) : a review of its use in the prevention of herpes zoster and post-herpetic neuralgia in adults aged >/=50 years. Drugs (2013) 73: p. 1227-1244
  8. Yawn BP., Wollan PC., Kurland MJ., St Sauver JL., Saddier P. : Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc (2011) 86: p. 88-93
  9. Arness T. et al. : Varicella zoster virus-associated disease in adulte kidney transplant recipients : incidence and risk-factor analysis. Transplant Infectious Disease (2008) 10: p. 260-268.
  10. Gourishankar S. et al. : Herpes Zoster Infection Following Solid Organ Transplantation : Incidence, Risk Factors and Outcomes in the Current Immunosuppressive Era. American Journal of Transplantation (2004) 4 : p. 108-115
  11. Meyers JD. : Congenital varicella in term infants: risk reconsidered. J Infect Dis (1974) 129: p. 215–217.
  12. Miller E., Cradock-Watson JE, Ridehalgh MK : Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet (1989) 2(8659): p. 371 – 373.
  13. Thürmann et al. : Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma. Eur J Clin Pharmacol (2001) 57: p. 235-241
  14. Hanngren K, Grandien M, Granström G. : Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis. (1985);17(4):343-7
  15. EMEA Commitee for Propietary Medicinal Products; Note for Guidance on plasma-derived medicinal products ; CPMP/BWP/269/95 1) (2001) rev. 3
  16. OMéd ; 01.01.2019; Section 5, Article 19
  17. Burnouf T et al.: Haemophilia (2003) 9(1): 24-37